Rapid Biosensor Systems

Rapid Biosensor Systems was a medical technology company that developed high-sensitivity, non-invasive screening tests for infectious diseases. The company's proprietary technology utilized a laser-based evanescent wave biosensor to detect pathogens directly from breath samples. Their primary product was a rapid TB Breathalyser designed to provide results within minutes at the point of care, specifically targeting global health challenges in developing regions. The company also adapted its platform for the detection of other pathogens, including SARS-CoV-2 during the COVID-19 pandemic. Based in Cambridge, UK, the company focused on providing rapid, low-cost diagnostic innovation before its dissolution in 2021.